Citation: K. Bashir et al., CLINICAL AND LABORATORY FEATURES OF PRIMARY PROGRESSIVE AND SECONDARYPROGRESSIVE MULTIPLE-SCLEROSIS, Annals of neurology, 44(3), 1998, pp. 99-99
Authors:
DUQUETTE P
GIRARD M
DUBOIS R
KOBLER RL
LUBLIN F
KELLEY L
FRANCIS GS
FREEDMAN M
GREENSTEIN JI
MISHRA B
DELILLIO N
WHITAKER J
LAYTON B
SIBLEY WA
LAGUNA J
KRIKAWA J
PATY DW
OGER JJ
KASTRUKOFF LF
MORRISON W
NELSON J
GOODIN D
MASSA SM
GUTTERIDGE E
ARNASON BGW
NORONHA A
REDER AT
MARTIA R
EBERS GC
RICE GPA
LESAUX J
JOHNSON KP
PANITCH HS
BEVER CT
CONWAY K
LI DKB
TANTON EL
ZHAO GJ
FLAK B
RIDDEBOUGH A
COVER K
RHODES B
COOK A
SMITH K
COSTLEY L
RENNEBERG S
SHAW T
GENTON M
VANDENNOORT S
WEINSHENKER B
WEISS W
REINGOLD S
TAYLOR W
WALLENBERG JC
BEDELL L
SIBLEY WA
EBERS GC
LUBLIN FD
PATY DW
REDER AT
Citation: P. Duquette et al., NEUTRALIZING ANTIBODIES DURING TREATMENT OF MULTIPLE-SCLEROSIS WITH INTERFERON BETA-1B - EXPERIENCE DURING THE FIRST 3 YEARS, Neurology, 47(4), 1996, pp. 889-894
Authors:
DUQUETTE P
DESPAULT L
KNOBLER RL
LUBLIN FD
KELLEY L
FRANCIS GS
FREEDMAN M
LAPIERRE Y
GREENSTEIN JI
MISHRA B
DELILLIO N
WHITAKER J
LAYTON B
SIBLEY WA
LAGUNA J
KRIKAWA J
PATY DW
OGER JJ
KASTRUKOFF LF
MORRISON W
NELSON J
GOODIN D
MASSA SM
GUTTERIDGE E
ARNASON BGW
NORONHA A
REDER AT
MARTIA R
EBERS GC
RICE GPA
LESAUX J
JOHNSON KP
PANITCH HS
BEVER CT
CONWAY K
LI DKB
TANTON EL
ZHAO GJ
FLAK B
RIDDEHOUGH A
COVER K
RHODES B
COOK A
SMITH K
COSTLEY L
RENNEBERG S
SHAW T
GENTON M
VANDENNOORT S
WEINSHENKER B
WEISS W
REINGOLD S
TAYLOR W
WALLENBERG JC
BEDELL L
Citation: P. Duquette et al., INTERFERON BETA-1B IN THE TREATMENT OF MULTIPLE-SCLEROSIS - FINAL OUTCOME OF THE RANDOMIZED CONTROLLED TRIAL, Neurology, 45(7), 1995, pp. 1277-1285
Authors:
DUQUETTE P
GIRARD M
DESPAULT L
DUBOIS R
KNOBLER RL
LUBLIN FD
KELLEY L
FRANCIS GS
LAPIERRE Y
ANTEL J
FREEDMAN M
HUM S
GREENSTEIN JI
MISHRA B
MULDOON J
WHITAKER JN
EVANS BK
LAYTON B
SIBLEY WA
LAGUNA J
KRIKAWA J
PATY DW
OGER JJ
KASTRUKOFF LF
MOORE GRW
HASHIMOTO SA
MORRISON W
NELSON J
GOODIN DS
MASSA SM
GUTTERIDGE E
ARNASON BGW
NORONHA A
REDER AT
MARTIA R
EBERS GC
RICE GPA
LESAUX J
JOHNSON KP
PANITCH HS
BEVER CT
CONWAY K
WALLENBERG JC
BEDELL L
VANDENNOORT S
WEINSHENKER B
WEISS W
REINGOLD S
PACHNER A
TAYLOR W
Citation: P. Duquette et al., INTERFERON BETA-1B IS EFFECTIVE IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS - CLINICAL-RESULTS OF A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, Neurology, 43(4), 1993, pp. 655-661
Authors:
PATY DW
LI DKB
DUQUETTE P
GIRARD M
DESPAULT L
DUBOIS R
KNOBLER RL
LUBLIN FD
KELLEY L
FRANCIS GS
LAPIERRE Y
ANTEL J
FREEDMAN M
HUM S
GREENSTEIN JI
MISHRA B
MULDOON J
WHITAKER JN
EVANS BK
LAYTON B
SIBLEY WA
LAGUNA J
KRIKAWA J
PATY DW
OGER JJ
KASTRUKOFF LF
MOORE GRW
HASHIMOTO SA
MORRISON W
NELSON J
GOODIN DS
MASSA SM
GUTTERIDGE E
ARNASON BGW
NORONHA A
REDER AT
MARTIA R
EBERS GC
RICE GPA
LESAUX J
JOHNSON KP
PANITCH HS
BEVER CT
CONWAY K
WALLENBERG JC
BEDELL L
VANDENNOORT S
WEINSHENKER B
WEISS W
REINGOLD S
PACHNER A
TAYLOR W
Citation: Dw. Paty et al., INTERFERON BETA-1B IS EFFECTIVE IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS .2. MRI ANALYSIS RESULTS OF A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, Neurology, 43(4), 1993, pp. 662-667